Status:
COMPLETED
Development of a Novel Human In Vitro Sarcoidosis Model
Lead Sponsor:
Elliott Crouser MD
Conditions:
Sarcoidosis
Eligibility:
All Genders
18-45 years
Brief Summary
There is currently no experimental model that accurately represents sarcoidosis. The lack of a useful research model significantly slows progress towards developing new treatments for sarcoidosis. The...
Detailed Description
Sarcoidosis is a systemic granulomatous disease of unknown cause, most commonly affecting the lungs, which tends to afflict young adults in the prime of their lives. Recent data indicating that sarcoi...
Eligibility Criteria
Inclusion
- sarcoidosis, subjects (18 - 45 years of age), including 30 sarcoidosis, 15 latent TB and 15 healthy controls.
Exclusion
- pregnant women
Key Trial Info
Start Date :
December 19 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 2 2017
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01857401
Start Date
December 19 2012
End Date
February 2 2017
Last Update
November 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Biomedical Research Tower, 10th floor
Columbus, Ohio, United States, 43221